Apple Approves Spotify App Update Following Court Decision

Published 8 hours agoAAPL

Apple Approves Spotify App Update Following Court Decision

In a significant development, Apple has greenlit an update for Spotify's U.S. app, allowing the streaming giant to display subscription prices and provide external payment links. This approval came after a landmark federal court ruling, highlighting a pivotal shift in the ongoing battle over Apple's App Store policies.

The catalyst for this change was a ruling by U.S. District Judge Yvonne Gonzalez Rogers. She determined that Apple must permit app developers to include external links for purchases without facing Apple's commission fees. As reported by Reuters, this decision directly challenged Apple's long-standing practice of collecting commissions on in-app transactions handled outside of Apple’s payment system.

Spotify welcomed the update, emphasizing that it plays a crucial role in ensuring transparency and consumer choice. Meanwhile, Apple has voiced its disagreement with the court's ruling but confirmed it would comply as it prepares an appeal. This approval has broader implications, reflecting ongoing legal and regulatory scrutiny of Apple's App Store operations and its fee structures.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Inspire Medical Systems Awaits Q1 2025 Earnings Release

Inspire Medical Systems Awaits Q1 2025 Earnings Release

15 minutes agoINSP

As of May 2, 2025, Inspire Medical Systems has not yet released its earnings report for Q1 2025. Historically, the company announces its quarterly results about a month after the period ends, which suggests that investors can expect the report in early June 2025. This timing has see investors keen to understand how the company's recent financial growth trends will continue. Inspire Medical's Q4 2024 results showed robust performance, with revenue reaching $239.7 million, marking a 25% increase compared to the previous year. The company also reported a gross margin of 85.0% and a net income of $35.2 million. The diluted earnings per share stood at $1.15. During the same quarter, Inspire activated 72 new U.S. centers, raising the total number to 1,435, and generated an operating cash flow of $69.2 million. Looking at the full year 2024, Inspire posted a revenue of $802.8 million, a 28% rise from the previous year. The company is targeting a revenue range of $940 million to $955 million for 2025, indicating a 17% to 19% growth year-over-year. Inspire's guidance for diluted EPS is between $2.10 and $2.20. Reuters noted that these figures underscore the company's positive trajectory as stakeholders anticipate its forthcoming disclosures.

Nine Energy Faces NYSE Non-Compliance Notice

Nine Energy Faces NYSE Non-Compliance Notice

30 minutes agoNINE

Nine Energy Service, Inc., listed on the NYSE under the symbol NINE, has received a notification from the New York Stock Exchange as of October 21, 2024, regarding its failure to meet certain listing criteria. The issue stems from the company's average global market capitalization and stockholders' equity falling below $50 million over a 30-day period. According to a report from Businesswire, Nine Energy Service has 45 days to put forward a plan to the NYSE, outlining how it will achieve compliance within the next 18 months. Should the NYSE accept their strategy, the company's shares will continue to be traded, albeit with quarterly reviews. Failing to meet the outlined standards, however, could trigger steps towards delisting from the exchange. Despite this notice, Nine Energy Service's core business operations remain unaffected by the NYSE's compliance concerns. The notice has not impacted their SEC filings nor triggered any defaults on major debts or agreements. Nonetheless, the announcement led to a roughly 4% dip in their stock price, which was trading at 98 cents per share, noted TradingView.

Liquidia's Stock Jumps 12% After Supreme Court Decision

Liquidia's Stock Jumps 12% After Supreme Court Decision

45 minutes agoLQDA

Liquidia Technologies' stock saw a significant 12% increase, climbing to $11.20, after the U.S. Supreme Court declined to review an appeal concerning the '793 patent of rival United Therapeutics on October 7, 2024. This decision effectively invalidates the patent, eliminating a major hurdle for Liquidia's Yutrepia product, as reported by marketscreener.com. The Supreme Court's move is a breakthrough for Liquidia, which is gearing up for Yutrepia's entry into the market. Yutrepia, approved tentatively by the FDA for treating adults with specific types of pulmonary hypertension, is awaiting final approval, anticipated once a competing product's exclusivity expires in May 2025. In light of the Supreme Court ruling, BTIG analysts have reaffirmed a "Buy" rating for Liquidia with a $25.00 price target, suggesting that the decision plays a crucial role in clearing Yutrepia's path to the market. Liquidia is now better positioned to compete with United Therapeutics' Tyvaso, which currently holds a significant market share. The Supreme Court ruling may expedite Yutrepia's market availability, allowing Liquidia to potentially attract customers from Tyvaso, pushing forward the company's strategic plans for a successful product launch.

CNO Financial Group Boosts Dividend and Share Buyback Program

CNO Financial Group Boosts Dividend and Share Buyback Program

CNO Financial Group, Inc. (NYSE: CNO) has announced a 6% increase in its quarterly dividend, pushing the payout to $0.17 per share from the previous $0.16. This marks the company's 13th consecutive annual dividend increase, highlighting its ongoing dedication to shareholder value. The new dividend rate will be payable on June 24, 2025, to those who are recorded as shareholders by June 10, 2025. In addition to the dividend bump, CNO Financial's board has approved an expansion of the share repurchase program by $500 million. This raises the total repurchase capacity to approximately $740.3 million as of December 31, 2024. The move comes ahead of the company's virtual annual meeting, slated for May 8, 2025. These financial maneuvers underscore CNO Financial Group's robust performance and its strategic efforts to enhance shareholder return. As noted by sources such as the company's investor relations page, the annual meeting will offer shareholders the opportunity to engage directly, emphasize corporate governance, and discuss future company endeavors.